Obstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Shanghai, China
Auto-generated profile, based on publicly available information
Rongmin Wang
Obstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Shanghai, China
To identify whether the use of a uterine manipulator (UM) or intracorporeal colpotomy conferred inferior short-term survival among patients treated for early-stage cervical cancer. Retrospective cohort study. Tertiary university-based hospital. 1169 patients with stage IB1 to IB2 cervical cancer. All patients underwent minimally invasive radical hysterectomy and pelvic lymphadenectomy. A total of 1169 patients diagnosed with preoperative stage IB1 to IB2 cervical cancer were primarily treated with surgery from 2018 to 2019. The eligible patients had a median age of 48 years (range, 23-76 years), and the median follow-up time was 34 months (range, 3.57-50.87 months). The 2-year overall survival rate of the patients with pathologic stage IB1 and IB2 was 99.8% and 98.8%, respectively, according to the 2018 International Federation of Gynecology and Obstetrics staging system. Univariable analysis revealed that the UM group had a 7.6-times higher risk of death than that of the manipulator-free group (p = .006), but multivariable analysis clarified that only tumor size (p = .016; hazard ratio, 2.285; 95% confidence interval, 1.166-4.479) and parametrial involvement (p = .003; hazard ratio, 3.556; 95% confidence interval, 1.549-8.166) were independent risk factors for overall survival. There was no statistically significant difference in survival between patients who underwent intracorporeal and protective colpotomy. Short-term survival outcomes in women undergoing minimally invasive radical hysterectomy for treatment of early-stage cervical cancer did not differ when a UM was avoided or when a protective colpotomy was performed.
Objective: This study aimed to elucidate the pathophysiological role of psychological distress in early-stage gestational hypertension (GH) through comprehensive assessment of its regulatory effects on disease progression and association with adverse pregnancy outcomes, thereby providing evidence-based support for early screening and intervention strategies. Methods: We conducted a prospective case-control study involving 446 patients with early-stage GH (diagnostic criteria: new-onset hypertension after 20 weeks of gestation, blood pressure ≥140/90 mmHg without proteinuria) and 200 normotensive pregnant women as controls. Psychological distress was assessed using the Self-Rated Anxiety Scale (SAS). A multidimensional statistical approach, including univariate analysis and multivariate logistic regression, was employed to systematically explore the risk factors that influence psychological distress. Pregnancy and perinatal outcomes were compared using Chi-square tests and t-tests. Results: The study revealed a markedly elevated prevalence of psychological distress in the early-stage GH group (20.9%) compared to controls (7.0%, P < 0.05). Multivariate analysis identified educational level (OR = 2.298, 95% CI [1.289–4.097]), history of adverse pregnancy (OR = 2.604, 95% CI [1.342–5.050]), and GH itself (OR = 1.859, 95% CI [1.213–2.850]) as independent risk factors for psychological distress. Follow-up data demonstrated that patients with psychological distress exhibited significantly higher rates of progression to preeclampsia (24.7% vs. 12.7%, P < 0.05), along with increased incidence of adverse pregnancy outcomes, including premature rupture of membranes, postpartum hemorrhage, neonatal infection, macrosomia, and low birth weight. Conclusions: This study provides a systematic characterization of psychological distress patterns in early stage GH patients and their potential impact on disease progression. Findings highlight the critical importance of integrating routine psychological screening and early intervention strategies into prenatal care for patients with GH to optimize maternal and neonatal outcomes.
20 February 2025 in Journal of Minimally Invasive Gynecology